Aiko Ito Selected Research

cucurbitacin F

9/2002

Ellagic acid derivatives and cytotoxic cucurbitacins from Elaeocarpus mastersii.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aiko Ito Research Topics

Disease

7	Fibrosis (Cirrhosis) 08/2023 - 06/2010
3	Heart Failure 11/2023 - 12/2021
3	Periodontitis 08/2023 - 12/2021
3	Myocardial Infarction 01/2013 - 06/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 12/2021
2	Hypertrophy 01/2019 - 05/2016
2	Bites and Stings (Sting) 01/2019 - 01/2016
2	Ischemia 09/2014 - 10/2009
1	Periodontal Diseases (Periodontal Disease) 01/2023
1	Atrial Remodeling 01/2020
1	Muscular Atrophy (Muscle Atrophy) 05/2016
1	Hypertrophy of Masticatory Muscles 05/2016
1	Obesity 01/2016
1	Teratoma (Teratoid Tumor) 06/2015
1	Macular Edema 01/2015
1	Necrosis 09/2014
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2013
1	Reperfusion Injury 01/2013
1	Wounds and Injuries (Trauma) 03/2012
1	Corneal Neovascularization 10/2009
1	Colonic Neoplasms (Colon Cancer) 01/2007
1	Body Weight (Weight, Body) 01/2007
1	Carcinogenesis 01/2007
1	Aberrant Crypt Foci 01/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2002

Drug/Important Bio-Agent (IBA)

4	Calcium-Calmodulin-Dependent Protein KinasesIBA 12/2021 - 05/2016
3	plerixafor FDA Link 01/2013 - 06/2010
2	Captopril (Capoten)FDA LinkGeneric 11/2023 - 01/2023
2	LipopolysaccharidesIBA 08/2023 - 01/2023
2	Vidarabine (Vira-A)FDA Link 08/2023 - 02/2022
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2019
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 12/2021 - 05/2016
2	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2013 - 03/2012
2	erucylphosphocholineIBA 03/2012 - 06/2010
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 08/2023
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	Drinking WaterIBA 01/2023
1	Adrenergic Agents (Adrenergic Drugs)IBA 02/2022
1	Propranolol (Inderal)FDA LinkGeneric 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2016
1	ClenbuterolIBA 05/2016
1	Polymethyl Methacrylate (Sol)IBA 05/2016
1	Proteins (Proteins, Gene)FDA Link 05/2016
1	Cyclic AMP (AMP, Cyclic)IBA 05/2016
1	Peptides (Polypeptides)IBA 09/2014
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2013
1	Messenger RNA (mRNA)IBA 03/2012
1	CollagenIBA 03/2012
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 03/2012
1	Chemokine CXCL12IBA 03/2012
1	Leptin ReceptorsIBA 03/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2009
1	Transcription Factors (Transcription Factor)IBA 10/2009
1	AzoxymethaneIBA 01/2007
1	EnzymesIBA 01/2007
1	PhytochemicalsIBA 01/2007
1	zapotinIBA 01/2007
1	Hexosaminidase A (Hex A)IBA 01/2007
1	Biomarkers (Surrogate Marker)IBA 01/2007
1	cucurbitacin DIBA 09/2002
1	AcidsIBA 09/2002
1	CucurbitacinsIBA 09/2002
1	cucurbitacin FIBA 09/2002
1	Ellagic AcidIBA 09/2002

Therapy/Procedure

2	Therapeutics 01/2016 - 06/2010
2	Subcutaneous Injections 01/2013 - 01/2007
1	Cell Transplantation 06/2015
1	Lasers (Laser) 01/2015
1	Light Coagulation 01/2015
1	Intramuscular Injections 09/2014
1	Surgical Amputation (Amputations) 09/2014
1	Aftercare (After-Treatment) 03/2012